What is Henan Lingrui Pharmaceutical Co., Ltd.'s (600285.SS) StockRank?

MoatMap's StockRank for Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) is 96/100, with a Strong Buy signal. This is a composite score combining Quality (75), Value (55), and Momentum (62) factor ranks across MoatMap's 20,000+ stock universe.

Does Henan Lingrui Pharmaceutical Co., Ltd. have an economic moat?

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Henan Lingrui Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Henan Lingrui Pharmaceutical Co., Ltd. in?

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600285.SS

STRONG BUYREMOVE

Henan Lingrui Pharmaceutical Co., Ltd. · Healthcare · China · $1.8B · Avg Vol: $20M/d

StockRank

P/E (TTM)

15.1x

ROE

22.6%

D/E

0.1x

Dividend %

5.3%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Henan Lingrui Pharmaceutical is a Chinese traditional medicine manufacturer. It lacks global scalability and does not align with our high-conviction macro themes.

COMPANY DESCRIPTION

Henan Lingrui Pharmaceutical Co., Ltd. manufactures and markets Traditional Chinese Medicine (TCM) plaster formulations, topical patches, and oral medicines. The company holds a dominant competitive moat in China's external analgesic plaster market, driven by its household brand name and extensive OTC pharmacy distribution network. It is a highly profitable niche pharmaceutical player with strong consumer brand loyalty.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	444M	489M	517M	570M	8.7%
EPS	0.12	0.15	0.19	0.20	17.0%
Shares	567M	567M	567M	567M	-0.1%
Debt	15M	22M	6M	59M	57.9%
Equity	377M	412M	454M	503M	10.1%
Op CF	123M	120M	129M	82M	-12.8%
Inv CF	-12M	-34M	-98M	-175M	—
Fin CF	-55M	-40M	-70M	-32M	—

PRICE (1M)-8.0%

SMA 50SMA 200

$2.99

RSI (14)

49.3

52W High

$3.47

From 52W High

0.9%

SCORE BREAKDOWN

Quality

ROIC

25.1%95.0

ROE

22.6%90.7

GP/Assets

56.6%89.7

Op. Margin

23.7%87.1

FCF/Assets

6.8%78.1

Piotroski

—55.7

Int. Cover

50.0x91.5

D/E Ratio

0.08x69.7

Current Ratio

1.17x15.0

Value

P/E (TTM)

15.1x72.3

EV/EBITDA

11.4x38.0

P/FCF

213.5x38.0

P/B

3.3x36.7

P/S

3.0x56.6

Div Yield

5.3%92.3

Momentum

52W High %

86%82.9

RS 6M

-12%66.1

SMA 50/200

0.99x59.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+18%32.2

Q Growth

14%56.8

FUNDAMENTALS

Market Cap

$1.8B

P/E (Forward)

12.8x

Gross Margin

80.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600285.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
600285.SS	Henan Lingrui Pharmaceutical Co., Ltd.(you)	$1.8B	96	STRONG BUY
600267.SS	Zhejiang Hisun Pharmaceutical Co., Ltd.	$1.8B	95	STRONG BUY
600211.SS	Tibet Rhodiola Pharmaceutical Holding Co.	$1.8B	96	STRONG BUY
600572.SS	Zhejiang CONBA Pharmaceutical Co.,Ltd.	$1.6B	94	STRONG BUY
1681.HK	Consun Pharmaceutical Group Limited	$1.5B	98	STRONG BUY
600750.SS	China Resources Jiangzhong Pharmaceutical Co.,Ltd	$2.4B	94	STRONG BUY
600216.SS	Zhejiang Medicine Co., Ltd.	$1.8B	89	STRONG BUY
002275.SZ	Guilin Sanjin Pharmaceutical Co., Ltd.	$1.2B	96	STRONG BUY
605507.SS	Guobang Pharma Ltd.	$1.8B	86	STRONG BUY
000650.SZ	Renhe Pharmacy Co.,Ltd	$1.1B	97	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) — Stock Score Summary

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) has a MoatMap StockRank of 96/100 based on Quality (75/100), Value (55/100), and Momentum (62/100) factor scores. The current signal is STRONG BUY. Henan Lingrui Pharmaceutical is a Chinese traditional medicine manufacturer. It lacks global scalability and does not align with our high-conviction macro themes.

Key Financial Metrics

Price	$2.99
Market Cap	$1.8B
P/E (TTM)	15.09
P/E (Forward)	12.79
Price/Book	3.25
Return on Equity	22.6%
Return on Invested Capital	25.1%
Debt/Equity	7.63
Gross Margin	80.3%
Operating Margin	23.7%
Revenue Growth	10.3%
Dividend Yield	5.3%
Free Cash Flow	$8M

Henan Lingrui Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Henan Lingrui Pharmaceutical Co., Ltd.’s (600285.SS) StockRank?: MoatMap’s StockRank for Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) is 96/100, with a Strong Buy signal. It is a composite of Quality (75), Value (55), and Momentum (62) factor ranks across MoatMap’s 20,000+ stock universe.
Does Henan Lingrui Pharmaceutical Co., Ltd. have an economic moat?: Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Henan Lingrui Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Henan Lingrui Pharmaceutical Co., Ltd. in?: Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).